Shows / Decera Clinical Education Oncology Podcast
Decera Clinical Education Oncology Podcast
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Decera Clinical Education. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
Episodes
Decera Clinical Education Oncology PodcastPARP Inhibitors in Pancreatic Cancer: Experts Discuss Importance of Testing for Biomarkers Along With Current Treatment Landscape
In this episode, Philip Agop Philip, MD, PhD, FRCP, and Elena Gabriela Chiorean, MD, discuss the importance of testing for biomarkers along with thecurrent…
Decera Clinical Education Oncology PodcastOptimal Dosing Strategies With Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer
In this episode, Kanwal Raghav, MD, and Rachel Riechelmann, MD, PhD, discuss key data supporting contemporary dosing strategies with the later-line treatment…
Decera Clinical Education Oncology PodcastFirst-Generation TRK Inhibitors: Clinical Evidence and Indications
In this episode, George D. Demetri, MD, and Alexander Drilon, MD, discuss key clinical data leading to FDA approvals and current indications for…
Decera Clinical Education Oncology PodcastPARP Inhibitors in Ovarian Cancer: Experts Discuss Patient Cases and the Current Paradigm
In this episode, Nicoletta Colombo, MD; Philipp Harter, MD, PhD; and Alexandra Leary, MD, PhD, discuss patient cases from a live webinar on the current…
Decera Clinical Education Oncology PodcastCounseling Patients and Caregivers on Prophylaxis Therapy for Severe Hemophilia A
In this episode, listen to Guy A. Young, MD, as he counsels a teenage patient with severe hemophilia A and the patient’s mother on various available treatment…
Decera Clinical Education Oncology PodcastRationale for NTRK Testing in Patients With Cancer
In this episode, George D. Demetri, MD, and Alexander Drilon, MD, discuss the biologic rationale behind testing for NTRK fusions in patients with various solid…
Decera Clinical Education Oncology PodcastExpert Answers to HCP Questions on Androgen Deprivation Therapy for Prostate Cancer
In this episode, Daniel W. Lin, MD; Alicia K. Morgans, MD, MPH; and David F. Penson, MD, answer audience questions from a live CCO webinar focused on current…
Decera Clinical Education Oncology PodcastExpert Insight on Important Clinical Trial Data From ESMO 2021 Informing Treatment for Endometrial and Ovarian Cancer
In this episode, Prof. Isabelle Ray-Coquard, MD, PhD, and Bernard Doger de Spéville, MD, PhD, provide expert insights on key new data from ESMO 2021 presented…
Decera Clinical Education Oncology PodcastExpert Insight on New Evidence Poised to Change the Treatment Landscape in Melanoma
In this podcast episode, Jeffrey S. Weber, MD, PhD; Allison Betof Warner, MD, PhD; and Hussein Tawbi, MD, PhD, discuss recent key data on adjuvant and…
Decera Clinical Education Oncology PodcastExpert Insight on Practice Changing From IGCS 2021 Informing Treatment for Endometrial, Ovarian, and Cervical Cancer
In this episode, Domenica Lorusso, MD, PhD, and Alexandra Leary, MD, PhD, provide expert insights on practice changing data from IGCS 2021 presented for…
Decera Clinical Education Oncology PodcastIntegrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address FAQs
In this episode, Paul G. Richardson, MD; Nina Shah, MD; and Peter M. Voorhees, MD, answer questions from a live webinar providing their thoughts on how to…
Decera Clinical Education Oncology PodcastExpert Insights on Optimal Use of CDK4/6 Inhibitors for HR-Positive/HER2-Negative Breast Cancer
In this episode, Dr. Joyce O’Shaughnessy, MD, leads an engaging discussion with Matthew P. Goetz, MD, and Sara Hurvitz, MD, FACP, on leveraging CDK4/6…
Decera Clinical Education Oncology PodcastEssential Biomarker Testing in GI Cancers
In this episode, John L. Marshall, MD, discusses current molecular testing considerations in the treatment of patients with gastrointestinal tumors, including…
Decera Clinical Education Oncology PodcastCDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Expert Answers to Clinician Questions
In this episode, Javier Cortes, MD, PhD; Stephen R. D. Johnston, MA, FRCP, PhD; and Sara Tolaney, MD, MPH, answer questions from an audience of healthcare…
Decera Clinical Education Oncology PodcastThe Latest Advances and Guidance in Nonmetastatic Castration-Resistant Prostate Cancer
In this episode, Karim Fizazi, MD, PhD, and Alicia K. Morgans, MD, MPH, discuss the clinical implications of the latest data on androgen receptor–targeting…
Decera Clinical Education Oncology PodcastManaging Serious Adverse Events Associated with BTK Inhibitor Treatment
In this podcast episode, Amy Goodrich, CRNP, discusses nursing perspectives on managing serious adverse events associated with BTK inhibitor therapy. Topics in…
Decera Clinical Education Oncology PodcastStrategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 2: Patient Strategies for Self-Management
In this podcast episode, Sandra E. Kurtin, PhD, ANP-C, AOCN, discusses nursing perspectives on avoiding adverse reactions to BTK inhibitor therapy. Topics in…
Decera Clinical Education Oncology PodcastStrategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 1: Drug–Drug and Drug–Food Interactions
In this podcast episode,Sandra E. Kurtin, PhD, ANP-C, AOCN, discusses nursing perspectives on avoiding adverse reactions to BTK inhibitor therapy. Topics in…
Decera Clinical Education Oncology PodcastAdverse Events Associated with BTK Inhibitor Treatment
In this podcast episode, Amy Goodrich, CRNP, discusses nursing perspectives on managing adverse events associated with BTK inhibitor therapy. Topics in this…
Decera Clinical Education Oncology PodcastBTK Inhibitors in CLL and Lymphomas: Overview and Current Indications
In this podcast episode, Beth Faiman, PhD, MSN, APRN-BC, AOCN, provides a nursing-focused overview on available BTK inhibitors in the treatment of CLL and…
Decera Clinical Education Oncology PodcastRadiopharmaceuticals in the Treatment of Metastatic Castration-Resistant Prostate Cancer
In this episode, Chris Parker, MD, and Bertrand Tombal, MD, PhD, discuss the clinical implications of the latest data on radiopharmaceuticals in the treatment…
Decera Clinical Education Oncology PodcastExpert Answers to HCP Questions on CAR T-Cell Therapy
In this episode, Caron A. Jacobson, MD; Jae H. Park, MD; and Noopur Raje, MD, answer audience questions from a live CCO webinar focused on current best…
Decera Clinical Education Oncology PodcastHow to Integrate Novel Treatment Classes for R/R Myeloma Into Clinical Practice: Information on BCMA-Targeted Therapies
In this podcast episode, Donna Catamero, ANP-BC, OCN, CCRC, highlights practical considerations for integrating anti-BCMA–targeted therapy into clinical…
Decera Clinical Education Oncology PodcastHow to Integrate Novel Treatment Classes for R/R Myeloma Into Clinical Practice: Information on Selinexor, Venetoclax, and Melphalan Flufenamide
In this podcast episode, Tiffany Richards, PhD, ANP-BC, AOCNP, highlights practical considerations for integrating novel treatments— selinexor, venetoclax, and…
Decera Clinical Education Oncology PodcastCaring for Patients With Newly Diagnosed Multiple Myeloma
In this podcast episode, Beth Faiman, PhD, MSN, APRN-BC, AOCN, discusses clinical considerations for diagnosis and optimal treatment selection for initial…
Decera Clinical Education Oncology PodcastTreatment Options for Patients With Multiple Myeloma After First Relapse
In this podcast episode,Charise Gleason, MSN, NP-BC, AOCNP, discusses clinical considerations for patients with multiple myeloma after relapse on initial…
Decera Clinical Education Oncology PodcastPrecision Medicine in Gynecologic Cancers: Expert Answers to Your Questions
In this episode, Linda R. Duska, MD, MPH; Robert L. Coleman, MD, FACOG, FACS; and Leslie Randall, MD, MAS, answer questions from an audience of healthcare…
Decera Clinical Education Oncology PodcastExpert Answers to Questions on Managing Neurofibromatosis Type 1 and MEK Inhibitors for NF1-Associated Plexiform Neurofibromas
In this episode, Scott R. Plotkin, MD, PhD, and Brian D. Weiss, MD, answer questions from a healthcare professional audience on topics related to NF1 and…
Decera Clinical Education Oncology PodcastExpert Answers to Questions on PARP Inhibitor Combinations in Prostate Cancer
In this episode, Wassim Abida, MD, PhD; Joaquin Mateo, MD, PhD; and Charles J. Ryan, MD, answer questions from an audience of healthcare professionals on…
Decera Clinical Education Oncology PodcastImmunotherapy for Advanced HCC: Current Options and Expert Answers to Clinician Questions
In this episode, David Kaplan, MD, MSc, and Thomas Karasic, MD, review approved immunotherapy options for advanced HCC and answer key questions surrounding use…
Decera Clinical Education Oncology PodcastExpert Insight on Key Data From ASCO 2021 Informing Treatment for Endometrial, Ovarian, and Cervical Cancer
In this episode, David Scott Miller, MD, FACOG, FACS, and Melissa M. Hardesty, MD, MPH, provide expert perspectives on new data from ASCO 2021 presented for…
Decera Clinical Education Oncology PodcastOptimizing Therapy for Relapsed/Refractory Multiple Myeloma: Expert Answers to Your Questions
In this podcast episode, Suzanne Lentzsch, MD, PhD, and Saad Z. Usmani, MD, MBA, FACP, discuss how they select optimal treatment for relapsed/refractory (R/R)…
Decera Clinical Education Oncology PodcastExperts Answer FAQs on Biomarker-Driven Therapy for Non-Small-Cell Lung Cancer
In this episode, Nathan Pennell, MD, PhD; Jamie E. Chaft, MD; and Stephen V. Liu, MD, answer questions asked by an audience of healthcare professionals during…
Decera Clinical Education Oncology PodcastCongress to Clinic: Post-ELCC Updates on Antibody–Drug Conjugates in NSCLC
In this episode,Egbert F. Smit, MD, PhD; David Planchard, MD, PhD; and Helena A. Yu, MD, answer audience questions from a live webinar regarding clinical data…
Decera Clinical Education Oncology PodcastImmunotherapy for Advanced HCC: Case Series
In this episode, Amit G. Singal, MD, MS, and Lipika Goyal, MD, discuss key considerations key considerations for hepatologists, oncologists, and other…
Decera Clinical Education Oncology PodcastIncorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Germany
In this episode, Georgios Gakis, MD, and Mario Wolfgang Kramer, MD, PhD, discuss key data on immune checkpoint inhibitors for urothelial carcinoma informing…
Decera Clinical Education Oncology PodcastManaging Toxicities Associated With FGFR Inhibitors in Urothelial Cancer and Beyond
In this episode, Ignacio Durán, MD, PhD, and Alison Birtle, MD, FRCP, FRCR, discuss toxicities associated with FGFR inhibitors used in the treatment of…
Decera Clinical Education Oncology PodcastOptimizing the Timing and Sequencing of Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer
In this episode, Joleen Hubbard, MD, and John L. Marshall, MD, discuss use of the later-line treatment options regorafenib and TAS-102 for patients with mCRC…
Decera Clinical Education Oncology PodcastExpert Answers to Questions on Contemporary Management of Multiple Myeloma
In this episode, Shaji K. Kumar, MD; Thomas G. Martin, MD; Philippe Moreau, MD; S. Vincent Rajkumar, MD, and Jesús F. San-Miguel, MD, PhD, answer audience…
Decera Clinical Education Oncology PodcastCombining PARP inhibitors With Other Treatments for Men With Prostate Cancer: Clinical Trial Updates
In this episode, Karim Fizazi, MD, PhD, and Joaquin Mateo, MD, PhD, consider the potential implications of ongoing and planned clinical trials using PARP…
Decera Clinical Education Oncology PodcastRationale for Combining PARP Inhibitors With Other Therapies in Prostate Cancer
In this episode, Karim Fizazi, MD, PhD, and Joaquin Mateo, MD, PhD, discuss the underlying rationale for using PARP inhibitors in combination with other…
Decera Clinical Education Oncology PodcastExpert Insight on Key Data From SGO 2021 Informing Treatment for Endometrial and Ovarian Cancer
In this episode, Jubilee Brown, MD, and Ursula Matulonis, MD, provide expert perspectives on new data from SGO 2021 presented for endometrial and ovarian…
Decera Clinical Education Oncology PodcastExpert Answers to Questions on PARP Inhibition for Prostate Cancer
In this episode, Charles J. Ryan, MD, and Neal D. Shore, MD, FACS, answer questions from a healthcare professional audience on topics related to prostate…
Decera Clinical Education Oncology PodcastExpert Insights on Highlights From ASH 2020 on Lymphomas/CLL
In this episode, Jeremy S. Abramson, MD, MMSc, discusses highlights of the key data from ASH 2020 on the treatment of patients with lymphomas/CLL, with topics…
Decera Clinical Education Oncology PodcastImproving Outcomes in EGFR-Mutated Non-Small-Cell Lung Cancer: Global Insights on Evolving Practice Standards
In this episode, Enriqueta Felip, MD, PhD, and Matthew Gubens, MD, MS, discuss evolving practice standards for EGFR-mutated non-small-cell lung cancer with…
Decera Clinical Education Oncology PodcastTargeting FGFR in Urothelial Cancer and Beyond
In this episode, Ignacio Durán, MD, PhD, and Alison Birtle, MD, FRCP, FRCR, interpret the latest clinical data on targeting FGFR in urothelial cancer…
Decera Clinical Education Oncology PodcastExpert Answers to HCP Questions on Pancreatic Cancer Treatment
In this episode, Michael J. Pishvaian, MD, PhD, and Rachna Shroff, MD, answer audience questions from a live CCO webinar focused on current best practices and…
Decera Clinical Education Oncology PodcastExpert Answers to HCP Questions on CAR T-Cell Therapies in Lymphoma
In this episode, Frederick L. Locke, MD, answers audience questions from a live CCO Webinar focused on emerging strategies in the use of CAR T-cell therapy for…
Decera Clinical Education Oncology PodcastFrequently Asked Questions on Emerging Antibody–Drug Conjugates in the Treatment of Advanced Non-Small-Cell Lung Cancer
In this episode, D. Ross Camidge, MD, PhD, and Joel W. Neal, MD, PhD, answer questions on investigational antibody-drug conjugates for advanced NSCLC…
Decera Clinical Education Oncology PodcastExpert Answers to HCP Questions on CAR T-Cell Therapies in Myeloma and Management of Key Toxicities
In this episode, Noopur Raje, MD, answers audience questions from a live CCO Webinar focused on emerging strategies in the use of CAR T-cell therapy for…
Decera Clinical Education Oncology PodcastExpert Insights on Highlights From ASH 2020 on Multiple Myeloma
In this episode, Dr. Shaji Kumar from the Mayo Clinic and Dr. Sagar Lonial from Emory University discuss highlights of the key data from ASH 2020 on the…
Decera Clinical Education Oncology PodcastExpert Insights on Key Data From ASH 2020 on Acute and Chronic Leukemias
In this episode, Jorge Cortes, MD, and Eunice S. Wang, MD, discuss the clinical implications of 3 key studies in acute myeloid leukemia (AML) and chronic…
Decera Clinical Education Oncology PodcastExpert Insight on Key Data From WCLC 2020 in Early-Stage Lung Cancer
In this episode, Jamie E. Chaft, MD, provides her expert perspective on new data from WCLC 2020 in early-stage NSCLC, with topics including: Updated results…
Decera Clinical Education Oncology PodcastIncorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Argentina
In this episode, José Ignacio Nolazco, MD, and Alejandro Nolazco, MD, discuss in Spanish the latest immuno-oncology developments in the treatment of urothelial…
Decera Clinical Education Oncology PodcastExpert Insights on Key Data From ASH 2020 on Nonmalignant Hematologic Disorders
In this episode, Hanny Al-Samkari, MD; Sujit Sheth, MD; and Mark A. Schroeder, MD, provide their clinical perspectives on new data from ASH 2020 on…
Decera Clinical Education Oncology PodcastExpert Insights on Key Data From ASH 2020 on Myelodysplastic Syndromes and Myeloproliferative Neoplasms
In this episode, Amy E. DeZern, MD, MHS, and Srdan Verstovsek, MD, provide medical oncology and hematology perspectives on new data from ASH 2020 in MDS and…
Decera Clinical Education Oncology PodcastExpert Answers to Questions on Contemporary Management of Hemophilia A
In this episode, Michael Callaghan, MD; Miguel A. Escobar, MD; and Rebecca Kruse-Jarres, MD, MPH, answer questions from a clinician audience on topics related…
Decera Clinical Education Oncology PodcastIncorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Italy
In this episode, Guiseppe Procopio, MD, and Cora N. Sternberg, MD, FACP, discuss in Italian the latest immuno-oncology developments in the treatment of…
Decera Clinical Education Oncology PodcastIncorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From the United States
In this episode, Petros Grivas, MD, PhD, and Jonathan E. Rosenberg, MD, discuss key data on immune checkpoint inhibitors for urothelial carcinoma informing…
Decera Clinical Education Oncology PodcastAn Expert Overview of Immunotherapy for Advanced HCC
Link to CME: Claim Credit In this episode, Amit G. Singal, MD, MS, and Lipika Goyal, MD, discuss key considerations in the contemporary use of immune…